Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11111246
APP PUB NO 20200223847A1
SERIAL NO

16705814

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to Substituted-Quinoxaline-Type Bridged-Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PURDUE PHARMA L PSTAMFORD CT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fuchino, Kouki Osaka, JP 15 99
Tsuno, Naoki Osaka, JP 37 264
Whitehead, John W F Newton, US 8 67
Yao, Jiangchao Princeton, US 61 876

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 7, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 7, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 7, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00